
Rakovina Therapeutics
Rakovina Therapeutics
Claim
We use cutting edge Deep Docking™ AI to target DNA-damage response (DDR) mechanisms and create innovative precision medicines with the potential to improve patient outcomes across multiple tumor types. DDR is a collection of processes that identify and correct DNA damage in our cells millions of times every day. Many cancers harbor a defect in natural DDR mechanisms that allow tumor cells to evade the human immune system and grow unchecked into life-threatening malignancies.We use cutting edge Deep Docking™ AI to target DNA-damage response (DDR) mechanisms and create innov Show More
Alpha Score
Alpha Score
41.6
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0